3004.20.00.20/Erythromycin Transdermal Patch 50mg/day/Japan

Erythromycin Transdermal Patch 50mg/day from Japan

Sustained-release transdermal patches delivering 50mg/day erythromycin for chronic acne, in individual retail pouches. Innovative delivery system still classified under HTS 3004.20.0020 as measured-dose antibiotic per heading description.

Duty Rate — Japan → United States

15%

Rate breakdown

9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate

9903.05.860%Universal product exemption (U.S. note 52(b))

9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)

Calculate with your customs value Verify classification with AI

Import Tips

• Adhesive residue and flux rate validation; 24-hour wear data

• Patch matrix composition declaration

• Avoid PVC backing materials